| Followers | 449 |
| Posts | 41478 |
| Boards Moderated | 5 |
| Alias Born | 09/26/2009 |
Friday, August 01, 2014 8:31:43 AM
Before you suggest that, please look at this....
Recent EPGL Twitter Updates--> 6/19,7/17,7/18,7/23, BELOW
EPGL Twitter Update 6/19/2014 ->
EPGL is leading the advance MEMS technology design and product development for one of the largest companies in its field. A NYSE
The relationship has expanded under phase two and involves co -ownership of product technologies under development. All EPGL technologies are involved. The technology and products will be manufactured by the NYSE company branded under its name and distributed worldwide by that Company and others affiliated. EPGL's role is that of research, design, development and ownership of the various technology applications.
We are developing an "open source" platform with this company to enable many other organizations and entities to create new products with a new platform. EPGL shareholders should realize that this situation is very real and developing. We are getting very much closer to the time we can reveal all. This will happen no later than August 29, 2014.
EPGL is unlike any other OTC Pink Sheet company at this time. Shareholders are right to be excited about our future. By the way, EPGL and our partners could make an announcement sooner that August 29, 2014.
From EPGL management and team, have a wonderful day.
EPGL Twitter Update 7/17/2014
Google took glucose lens as far as they could. Now the "X" man is an ex-man. Enter Novartis to try to figure it out. But Novartis reached out to EPGL not long ago. So whose technology will dominate coming smart lens revolution?
EPGL is leading giants and focused on new smart lens technologies which will enable mass marketing in both health and consumer electronics well into the future.
Many companies and institutions stand to be enabled by our work. EPGL is working with the best in the business and more is to come by August 29, 2014. EPGL shareholders should be excited at the prospects. Have a wonderful weekend from EPGL team.
TWITTER UPDATE 7/18/2014
It can now be revealed that both Novartis and Google reached out to our development team members in recent weeks and months.
This fact should be a clue to the gravity and know-how of our team in both BioMEMS and manufacturing of smart contact lenses.
We intend to set the industry's standard with our enabling technology. Who are we teamed up with? Who will ultimately include EPGL originated technology within their coming smart lenses? August 29th or before, we intend to go into more details as we've previously announced.
TWITTER UPDATES 7/23/2014
Here's an example of the caliber of suitors. Who did we choose to team our technology with? 1/2
The best in the business. Find out soon... 2/2
Recent EPGL Twitter Updates--> 6/19,7/17,7/18,7/23, BELOW
EPGL Twitter Update 6/19/2014 ->
EPGL is leading the advance MEMS technology design and product development for one of the largest companies in its field. A NYSE
The relationship has expanded under phase two and involves co -ownership of product technologies under development. All EPGL technologies are involved. The technology and products will be manufactured by the NYSE company branded under its name and distributed worldwide by that Company and others affiliated. EPGL's role is that of research, design, development and ownership of the various technology applications.
We are developing an "open source" platform with this company to enable many other organizations and entities to create new products with a new platform. EPGL shareholders should realize that this situation is very real and developing. We are getting very much closer to the time we can reveal all. This will happen no later than August 29, 2014.
EPGL is unlike any other OTC Pink Sheet company at this time. Shareholders are right to be excited about our future. By the way, EPGL and our partners could make an announcement sooner that August 29, 2014.
From EPGL management and team, have a wonderful day.
EPGL Twitter Update 7/17/2014
Google took glucose lens as far as they could. Now the "X" man is an ex-man. Enter Novartis to try to figure it out. But Novartis reached out to EPGL not long ago. So whose technology will dominate coming smart lens revolution?
EPGL is leading giants and focused on new smart lens technologies which will enable mass marketing in both health and consumer electronics well into the future.
Many companies and institutions stand to be enabled by our work. EPGL is working with the best in the business and more is to come by August 29, 2014. EPGL shareholders should be excited at the prospects. Have a wonderful weekend from EPGL team.
TWITTER UPDATE 7/18/2014
It can now be revealed that both Novartis and Google reached out to our development team members in recent weeks and months.
This fact should be a clue to the gravity and know-how of our team in both BioMEMS and manufacturing of smart contact lenses.
We intend to set the industry's standard with our enabling technology. Who are we teamed up with? Who will ultimately include EPGL originated technology within their coming smart lenses? August 29th or before, we intend to go into more details as we've previously announced.
TWITTER UPDATES 7/23/2014
Here's an example of the caliber of suitors. Who did we choose to team our technology with? 1/2
The best in the business. Find out soon... 2/2
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
